This article distills from available data descriptions of typical human symptoms in reaction to prompt total-body ionizing radiation in the dose range 0.5 to 30 Gy midline body tissue. The symptoms are correlated with dose and time over the acute postexposure period of 6 wk. The purpose is to provide a symptomatology basis for assessing early functional impairment of individuals who may be involved in civil defense, emergency medical care and various military activities in the event of a nuclear attack. The dose range is divided into eight subranges associated with important pathophysiological events. For each subrange, signs and symptoms are designated including estimates of symptom onset, severity, duration and incidence.
Publ reporting burden for thiscollection of Infom tion is estmlted to average 1 hour p repiolns Including the time for reviewing instructions, serchinig existing data sOurces gathering and maintaining the "dt neded. Approved for public release; distribution is unlimited.
ABSTRACT (Maximum 200 words)One hundred and seventy one references applicable to determining the effect of tactical nuclear weapons on military personnel have been reviewed, and the signifi-ant conclusions are reported. The study reviews the scientific literature and focuses on animal experiments published from 1933 to the present time, including a number of German studies and some Soviet research not previously reviewed in English language publications. Recurring themes of the review are the synergistic increase in mortality when injury (burn, wound, bleeding, fracture, etc.) follows irradiation and the reduction in mortality when injury precedes irradiation and/or when antibiotics are administered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.